An Italian research group has developed a micromechanical antibiogram for bacterial infection analysis (a new device to detect bacteria movements). They are looking for research collaborations with companies involved in the production of medical and analytical instrumentation. A regional grant can support the co-development of the research results by paying the costs of one year research fellowship.
The Italian research group has developed a device that detects bacteria movements. The bacteria are grown on a small micromechanical sensor, and when they are alive their motion is detected by the sensor and amplified. When the bacteria are killed by the proper antibiotic they stop moving and no signal is detected. The approach proposed may implements an higly packed large array of sensors (up to 1000 sensors over a 1cm squared chip) with a suitable microfluidic circuit for the individual antibiotic delivery: this combination may, in principle, consent to screen up to 1000 different molecules on the same chip.
They are preparing a project proposal that can fund (thanks to a regional programme) one year fellowship grant.
They are looking for a company active in the field of medical and analytical instrumentation interested in the co-development of the technology. The company role will be to collaborate with the research group and the dedicated fellow in order to achieve a proof-of-concept (potentially ready to be used by the company).
Deadline of the call: 30/08/2017
Deadline for EoIs: 15/07/2017
- Specific area of activity of the partner: Type: companies involved in the production of medical and analytical instrumentation.
Role: co-development of the research results with the aim of being exploited by the company.
The technology is an alternative approach that can provide results in real time on the effective microbial susceptibility to specific antibiotics, improving the prognosis and the healing of the patient and reducing mortality risk and hospitalization costs. This time reduction would allow achieving faster treatments tailored to the patient, which would be more effective and better tolerated. Antibiograms are sensitive only to the suppression of the bacteria replication process and after the treatment the bacteria may be still alive and start a recurrences after several days. The micromechanical sensor proposed allows to detect the vitality of the bacteria and can discriminate between dead and alive bacteria, thus selecting the proper antibiotic to treat the infection. Moreover the technology can evaluate in parallel hundreds of different antibiotic molecules, speeding up the screening drug rates.
24/04/2018 - Selling Online Internationally - Inverary